Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedMar 02, 2026
DataAggregated Company Financials
Companies9
  • 7D6.1%
  • 3M-15.0%
  • 1Y-7.2%
  • YTD-3.4%

Over the last 7 days, the Life Sciences industry has risen 5.0%, driven by gains from AddLife of 7.2%. In the same time, Magle Chemoswed Holding was down 11%. In the past year, the industry is down 7.6%. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 02 Mar 2026SEK 29.1bSEK 14.6b-SEK 838,240,147.0033.6x-34.7x2x
Wed, 28 Jan 2026SEK 28.7bSEK 14.9b-SEK 744,515,427.0044.3x-38.5x1.9x
Fri, 26 Dec 2025SEK 31.5bSEK 14.9b-SEK 744,515,427.0050.2x-42.4x2.1x
Sun, 23 Nov 2025SEK 33.3bSEK 14.9b-SEK 744,515,427.0055.4x-44.7x2.2x
Tue, 21 Oct 2025SEK 34.6bSEK 14.7bSEK 61.3m55.1x564.4x2.4x
Thu, 18 Sep 2025SEK 36.2bSEK 14.7bSEK 61.3m60.3x591.1x2.5x
Sat, 16 Aug 2025SEK 34.9bSEK 14.8bSEK 161.3m58.6x216.2x2.4x
Mon, 14 Jul 2025SEK 47.2bSEK 16.6bSEK 416.3m67.9x113.4x2.8x
Wed, 11 Jun 2025SEK 47.0bSEK 16.6bSEK 404.2m71.1x116.3x2.8x
Fri, 09 May 2025SEK 46.1bSEK 16.6bSEK 422.0m44.4x109.3x2.8x
Sun, 06 Apr 2025SEK 34.6bSEK 16.6bSEK 609.4m36.8x56.8x2.1x
Tue, 04 Mar 2025SEK 40.3bSEK 16.6bSEK 615.4m40.9x65.5x2.4x
Thu, 30 Jan 2025SEK 39.8bSEK 16.7b-SEK 1,152,911,426.0043.1x-34.5x2.4x
Sat, 28 Dec 2024SEK 44.2bSEK 16.7b-SEK 1,152,911,426.0050.9x-38.3x2.6x
Mon, 25 Nov 2024SEK 42.5bSEK 16.8b-SEK 948,723,426.0048.3x-44.8x2.5x
Wed, 23 Oct 2024SEK 47.5bSEK 16.7b-SEK 988,175,491.0078.9x-48.1x2.9x
Fri, 20 Sep 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0058.1x-47.6x2.8x
Sun, 18 Aug 2024SEK 48.2bSEK 16.7b-SEK 1,124,972,538.0061.5x-42.9x2.9x
Tue, 16 Jul 2024SEK 47.0bSEK 16.3b-SEK 1,188,686,510.0058x-39.5x2.9x
Thu, 13 Jun 2024SEK 43.1bSEK 16.3b-SEK 1,188,686,510.0058.4x-36.2x2.6x
Sat, 11 May 2024SEK 40.3bSEK 16.3b-SEK 1,157,635,671.0036.5x-34.8x2.5x
Mon, 08 Apr 2024SEK 39.3bSEK 16.0b-SEK 1,122,792,213.0037.3x-35x2.5x
Wed, 06 Mar 2024SEK 37.5bSEK 16.0b-SEK 1,123,139,210.0039.4x-33.4x2.3x
Fri, 02 Feb 2024SEK 39.3bSEK 15.6b-SEK 1,371,823,683.0046.7x-28.7x2.5x
Sun, 31 Dec 2023SEK 37.7bSEK 15.5b-SEK 1,393,723,683.0045.7x-27x2.4x
Tue, 28 Nov 2023SEK 33.8bSEK 15.4b-SEK 1,395,872,683.0039.1x-24.2x2.2x
Thu, 26 Oct 2023SEK 25.2bSEK 15.1b-SEK 1,134,516,711.0032.5x-22.2x1.7x
Sat, 23 Sep 2023SEK 27.5bSEK 15.1b-SEK 1,133,713,072.0038.8x-24.3x1.8x
Mon, 21 Aug 2023SEK 29.6bSEK 15.1b-SEK 213,871,038.0042.4x-138.4x2x
Wed, 19 Jul 2023SEK 31.4bSEK 14.9b-SEK 238,476,038.0041.6x-131.7x2.1x
Fri, 16 Jun 2023SEK 40.9bSEK 14.6b-SEK 172,476,038.0038.7x-236.9x2.8x
Sun, 14 May 2023SEK 38.1bSEK 14.6b-SEK 205,506,792.0038.3x-185.4x2.6x
Tue, 11 Apr 2023SEK 32.7bSEK 14.6b-SEK 57,449,459.0032.1x-569.8x2.2x
Thu, 09 Mar 2023SEK 36.1bSEK 14.6b-SEK 57,185,459.0030.2x-631.7x2.5x
Price to Earnings Ratio

-631.7x


Total Market Cap: SEK 36.1bTotal Earnings: -SEK 57,185,459.00Total Revenue: SEK 14.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -17.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market1.88%
Healthcare0.51%
Life Sciences6.10%
Clinical Research and Equipment6.10%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 154.207.3%
+SEK 1.3b		-5.3%PE33.6x
MCAP MedCapSEK 489.505.4%
+SEK 375.5m		27.6%PE33.4x
PRO PromimicSEK 11.0015.3%
+SEK 27.6m		-60.6%PS3.9x
GENO Genovis AB (publ.)SEK 17.302.0%
+SEK 22.5m		-36.9%PE48.6x
LEVBIO Level BioSEK 0.4011.0%
+SEK 2.7m		34.7%PS0.9x

Latest News

PRO
SEK 11.00
Promimic
7D
15.3%
1Y
-60.6%
IDLDX
SEK 0.36
IDL Diagnostics
7D
-5.5%
1Y
-37.8%
BICO
SEK 18.26
BICO Group
7D
-0.9%
1Y
-50.2%
GENO
SEK 17.30
Genovis AB (publ.)
7D
2.0%
1Y
-36.9%
MCAP
SEK 489.50
MedCap
7D
5.4%
1Y
27.6%
LEVBIO
SEK 0.40
Level Bio
7D
12.8%
1Y
33.8%
ALIF B
SEK 154.20
AddLife
7D
7.3%
1Y
-5.3%

Investors Shouldn't Be Too Comfortable With AddLife's (STO:ALIF B) Earnings

Feb 12
Investors Shouldn't Be Too Comfortable With AddLife's (STO:ALIF B) Earnings
MAGLE
SEK 8.00
Magle Chemoswed Holding
7D
-11.1%
1Y
-74.4%

Market Cool On Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Revenues Pushing Shares 28% Lower

Jan 27
Market Cool On Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Revenues Pushing Shares 28% Lower
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%